Literature DB >> 25124055

Cytostatic drugs and metabolites in municipal and hospital wastewaters in Spain: filtration, occurrence, and environmental risk.

Noelia Negreira1, Miren López de Alda2, Damià Barceló3.   

Abstract

Concerns about cytostatic anticancer drugs in the environment are increasing, mainly due to the lack of knowledge about the fate and impact of these cytotoxic compounds in the water cycle. In this context, the present work investigated the occurrence of 13 cytostatics and 4 metabolites in wastewater samples from various wastewater treatment plants (WWTPs) and from a large hospital from Spain. The target compounds belong to five different classes according to the Anatomical Therapeutic Classification (ATC), namely, alkylating agents, antimetabolites, plant alkaloids and other natural products, cytotoxic antibiotics and related substances, and other antineoplastic agents. Some of them have been classified as carcinogens in humans by the International Agency for Research on Cancer (IARC). These compounds were determined by an automated on line solid-phase extraction-liquid chromatography-tandem mass spectrometry (SPE-LC-MS/MS) method. Results showed the presence of methotrexate (MET), ifosfamide (IF), cyclophosphamide (CP), irinotecan (IRI), doxorubicin (DOX), capecitabine (CAP), tamoxifen (TAM) and the metabolites endoxifen (OH-D-TAM), hydroxytamoxifen (OH-TAM) and hydroxypaclitaxel (OH-PAC) at levels ranging from 2 ng L(-1) (for MET) to 180 ng L(-1) (for TAM). Some of these compounds were found to be efficiently removed after wastewater treatment, e.g. MET, DOX and IRI, whereas other compounds, such as TAM, CP and IF remained largely unaltered. The behaviour of the target compounds during the common filtration step of the water samples was also investigated with the finding that some compounds are strongly adsorbed to nylon filters, while cellulose acetate appears as the best choice for the filter material. The aquatic environmental risk associated to the detected compounds was also assessed. To the best of the authors' knowledge, this is the first report of the presence of the metabolites OH-D-TAM and OH-TAM in the water cycle.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytostatics; Filtration; Liquid chromatography-mass spectrometry; Occurrence; Risk assessment; Wastewater

Mesh:

Substances:

Year:  2014        PMID: 25124055     DOI: 10.1016/j.scitotenv.2014.07.101

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  17 in total

1.  Occurrence and fate of selected anticancer, antimicrobial, and psychotropic pharmaceuticals in an urban river in a subcatchment of the Yodo River basin, Japan.

Authors:  Takashi Azuma; Hirotaka Ishiuchi; Tomomi Inoyama; Yusuke Teranishi; Misato Yamaoka; Takaji Sato; Yoshiki Mino
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-17       Impact factor: 4.223

2.  Distribution of six anticancer drugs and a variety of other pharmaceuticals, and their sorption onto sediments, in an urban Japanese river.

Authors:  Takashi Azuma; Natsumi Arima; Ai Tsukada; Satoru Hirami; Rie Matsuoka; Ryogo Moriwake; Hirotaka Ishiuchi; Tomomi Inoyama; Yusuke Teranishi; Misato Yamaoka; Mao Ishida; Kanae Hisamatsu; Ayami Yunoki; Yoshiki Mino
Journal:  Environ Sci Pollut Res Int       Date:  2017-06-28       Impact factor: 4.223

3.  Toxicity of the mixture of selected antineoplastic drugs against aquatic primary producers.

Authors:  Tina Elersek; Sara Milavec; Maša Korošec; Polona Brezovsek; Noelia Negreira; Bozo Zonja; Miren López de Alda; Damià Barceló; Ester Heath; Janez Ščančar; Metka Filipič
Journal:  Environ Sci Pollut Res Int       Date:  2016-01-12       Impact factor: 4.223

4.  Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments.

Authors:  Marjeta Česen; Tina Kosjek; Francesco Busetti; Boris Kompare; Ester Heath
Journal:  Environ Sci Pollut Res Int       Date:  2016-02-27       Impact factor: 4.223

5.  Determination of cytostatic drugs in Besòs River (NE Spain) and comparison with predicted environmental concentrations.

Authors:  Helena Franquet-Griell; Deborah Cornadó; Josep Caixach; Francesc Ventura; Silvia Lacorte
Journal:  Environ Sci Pollut Res Int       Date:  2017-01-10       Impact factor: 4.223

6.  Analyses of combined effects of cytostatic drugs on micronucleus formation in the Tradescantia.

Authors:  Miroslav Mišík; Metka Filipic; Armen Nersesyan; Katarína Mišíková; Siegfried Knasmueller; Michael Kundi
Journal:  Environ Sci Pollut Res Int       Date:  2015-12-01       Impact factor: 4.223

7.  Prediction and assessment of ecogenotoxicity of antineoplastic drugs in binary mixtures.

Authors:  Michael Kundi; Alfredo Parrella; Margherita Lavorgna; Emma Criscuolo; Chiara Russo; Marina Isidori
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-03       Impact factor: 4.223

8.  First inter-laboratory comparison exercise for the determination of anticancer drugs in aqueous samples.

Authors:  Ester Heath; Marjeta Česen; Noelia Negreira; Miren Lopez de Alda; Laura Ferrando-Climent; Lucie Blahova; Tung Viet Nguyen; Mohamed Adahchour; Achim Ruebel; Neville Llewellyn; Janez Ščančar; Srdjan Novaković; Vesna Mislej; Marjeta Stražar; Damià Barceló; Tina Kosjek
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-15       Impact factor: 4.223

9.  The effects and the toxicity increases caused by bicarbonate, chloride, and other water components during the UV/TiO2 degradation of oxazaphosphorine drugs.

Authors:  Webber Wei-Po Lai; Ying-Chih Chuang; Angela Yu-Chen Lin
Journal:  Environ Sci Pollut Res Int       Date:  2017-04-27       Impact factor: 4.223

10.  Complexation of 5-Fluorouracil with β-Cyclodextrin and Sodium Dodecyl Sulfate: A Useful Tool for Encapsulating and Removing This Polluting Drug.

Authors:  Ana M T D P V Cabral; Ana C G Fernandes; Neuza A M Joaquim; Francisco Veiga; Sara P C Sofio; Isabel Paiva; Miguel A Esteso; M Melia Rodrigo; Artur J M Valente; Ana C F Ribeiro
Journal:  Toxics       Date:  2022-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.